Carl Llor

8.1k total citations · 1 hit paper
188 papers, 4.3k citations indexed

About

Carl Llor is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Carl Llor has authored 188 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 73 papers in Pulmonary and Respiratory Medicine and 72 papers in Applied Microbiology and Biotechnology. Recurrent topics in Carl Llor's work include Antibiotic Use and Resistance (72 papers), Pneumonia and Respiratory Infections (51 papers) and Respiratory and Cough-Related Research (49 papers). Carl Llor is often cited by papers focused on Antibiotic Use and Resistance (72 papers), Pneumonia and Respiratory Infections (51 papers) and Respiratory and Cough-Related Research (49 papers). Carl Llor collaborates with scholars based in Spain, Denmark and United Kingdom. Carl Llor's co-authors include Lars Bjerrum, Josep M. Cots, Marc Miravitlles, Ana Moragas, Sílvia Hernández, Carolina Bayona, Karlos Naberán, Christopher Butler, Nick Francis and Jesús Molina and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Carl Llor

165 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem

2014 1.3k citations Carl Llor, Lars Bjerrum profile →

Peers

Countries citing papers authored by Carl Llor

Since Specialization

Citations

This map shows the geographic impact of Carl Llor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Llor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Llor more than expected).

Fields of papers citing papers by Carl Llor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Llor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Llor. The network helps show where Carl Llor may publish in the future.

Co-authorship network of co-authors of Carl Llor

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Llor. A scholar is included among the top collaborators of Carl Llor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Llor. Carl Llor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors influencing urinary tract infection prevention and antibiotic stewardship in European nursing homes: an interview study with staff 2025 ·European Geriatric Medicine ·(unknown), Alexandra Brandt Ryborg Jønsson, Jette Nygaard Jensen, (unknown), Malene Plejdrup Hansen, Carl Llor, (unknown), Ana Moragas, (unknown), (unknown), Anna Kowalczyk, (unknown), (unknown), Agapi Angelaki, Jesper Lykkegaard	0
2	Duration of severe and moderate symptoms in pharyngitis by cause 2024 ·Atención Primaria ·Ana Moragas, (unknown), (unknown), (unknown), (unknown), Carl Llor	0
3	Global restriction of the over-the-counter sale of antimicrobials: does it make sense? 2024 ·Frontiers in Public Health ·Carl Llor, Ria Benkő, (unknown)	6
4	Antibiotic use in Barcelona in 2023 in primary care and the potential reduction by adjusting box sizes to current guidelines 2024 ·Revista Española de Quimioterapia ·Carl Llor, (unknown), (unknown)	1
5	Optimising antibiotic exposure by customising the duration of treatment for respiratory tract infections based on patient needs in primary care 2024 ·EClinicalMedicine ·Carl Llor, Jens Kjølseth Møller, Marc Miravitlles, Gunnar Kahlmeter, Lars Bjerrum	3
6	Perception and views about individualising antibiotic duration for respiratory tract infections when patients feel better: a qualitative study with primary care professionals 2024 ·BMJ Open ·Ana Moragas, (unknown), Josep M. Cots, (unknown), Lars Bjerrum, Carl Llor	3
7	C-reactive protein point-of-care testing and complementary strategies to improve antibiotic stewardship in children with acute respiratory infections in primary care 2023 ·Frontiers in Pediatrics ·Annamaria Staiano, Lars Bjerrum, Carl Llor, Hasse Melbye, Rogier Hopstaken, Ivan Gentile, Andreas Plate, Oliver van Hecke, Jan Y. Verbakel	5
8	Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD 2022 ·SHILAP Revista de lepidopterología ·David Gillespie, Nick Francis, Haroon Ahmed, Kerenza Hood, Carl Llor, Patrick White, Emma Thomas‐Jones, (unknown), Bernadette Sewell, Rhiannon Phillips, Gurudutt Naik, Hasse Melbye, Rachel Lowe, Nigel Kirby, (unknown), Janine Bates, M Fasihul Alam, Christopher Butler	1
9	Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial 2022 ·Family Practice ·Carl Llor, Ana Moragas, Dan Ouchi, (unknown), (unknown), Ainhoa Gómez-Lumbreras, (unknown), Jesús Pujol Salud, Rosa Morros	6
10	Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis 2022 ·Pulmonary Pharmacology & Therapeutics ·Carl Llor, Ana Moragas, Marc Miravitlles, (unknown), Gloria Córdoba	7
11	Best methods for urine sample collection for diagnostic accuracy in women with urinary tract infection symptoms: a systematic review 2022 ·Family Practice ·Carl Llor, Ana Moragas, (unknown), (unknown), (unknown), Rosa Morros	4
12	Diagnostic and Therapeutic Management of Urinary Tract Infections in Catalonia, Spain: Protocol for an Observational Cohort Study 2022 ·JMIR Research Protocols ·Ana Moragas, (unknown), Carl Llor, Dan Ouchi, (unknown), Mónica Monteagudo, (unknown), Maria Giner‐Soriano	4
13	Clinical effectiveness and bacteriological eradication of three different Short-COurse antibiotic regimens and single-dose fosfomycin for uncomplicated lower Urinary Tract infections in adult women (SCOUT study): study protocol for a randomised clinical trial 2021 ·BMJ Open ·(unknown), Rosa Morros, (unknown), Laura Medina‐Perucha, Alfonso Leiva, Joana Ripoll, (unknown), Cruz Bartolomé-Moreno, Rosa Magallón Botaya, (unknown), José Molero, Ana Moragas, (unknown), (unknown), Carl Llor	5
14	Reducing antibiotic prescribing for lower respiratory tract infections 6 years after a multifaceted intervention 2019 ·International Journal of Clinical Practice ·José Molero, Ana Moragas, Beatríz González López-Valcarcel, Lars Bjerrum, Josep M. Cots, Carl Llor	3
15	Misconceptions of Spanish general practitioners' attitudes toward the management of urinary tract infections and asymptomatic bacteriuria: an internet-based questionnaire study. 2017 ·PubMed ·Carl Llor, Ana Moragas, Sílvia Hernández, (unknown), Josep M. Cots	10
16	Survey of Spanish general practitioners’ attitudes toward management of sore throat: an internet-based questionnaire study 2017 ·BMC Family Practice ·Carl Llor, Isabel Vilaseca, Eduardo Lehrer, (unknown), (unknown), Ana Moragas, Josep M. Cots	8
17	The STOP-AB trial protocol: efficacy and safety of discontinuing patient antibiotic treatment when physicians no longer consider it necessary 2017 ·BMJ Open ·Carl Llor, Ana Moragas, Carolina Bayona, Josep M. Cots, José Molero, (unknown), (unknown), Isabel Gutiérrez, (unknown), (unknown), (unknown), (unknown), (unknown)	9
18	Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study 2015 ·Respiratory Medicine ·Míriam Barrecheguren, Mónica Monteagudo, Jaume Ferrer, (unknown), Carl Llor, Cristina Esquinas, Marc Miravitlles	76
19	El cumplimiento del tratamiento antibiótico en la faringitis aguda es muy bajo, principalmente con antibióticos que se toman tres veces al día 2009 ·Revista española de quimioterapia. Suplemento ·Carl Llor, (unknown), (unknown), Carolina Bayona, M. Hernández, Ana Moragas, (unknown)	5
20	Criteria for selecting and using non-steroidal anti-inflammatory drugs in primary health care 2000 ·Family Practice ·(unknown), Sílvia Paredes, Carl Llor	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact